SEC Form SC 13G filed by MoonLake Immunotherapeutics

	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
	SCHEDULE 13G
	Under the Securities Exchange Act of 1934
	(Amendment No.  __)*
	MoonLake Immunotherapeutics
	(Name of Issuer)
	Class A Ordinary Shares
	(Title of Class of Securities)

	61559X104
	(CUSIP Number)

	December 31, 2022†
	(Date of Event which Requires Filing of this Statement)

[x]	Rule 13d-1(b)

[ ]	Rule 13d-1(c)

[ ]	Rule 13d-1(d)

1	Names of Reporting Persons.   Bihua Chen
2	Check the Appropriate Box if a Member of a Group (See Instructions)
	(a) [ ]
	(b) [x]
3	SEC Use Only
4	Citizenship or Place of Organization.   United States
Number of Shares Beneficially Owned by Each Reporting Person With		5 Sole Voting Power   0 shares
		6 Shared Voting Power   6,892,100 shares Refer to Item 4 below.
		7 Sole Dispositive Power   0 shares
		8 Shared Dispositive Power   6,892,100 shares Refer to Item 4 below.
9	Aggregate Amount Beneficially Owned by Each Reporting Person   6,892,100 shares Refer to Item 4 below.
10	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)     [ ] N/A
11	Percent of Class Represented by Amount in Row (9)*   17.60%   Refer to Item 4 below.
12	Type of Reporting Person (See Instructions)   HC, IN (Control Person, Individual)

CUSIP NO.

61559X104

	(a)	Name of Issuer
		MoonLake Immunotherapeutics
	(b)	Address of Issuer’s Principal Executive Offices
		Dorfstrasse 29, Zug, Switzerland 6300

	(a)	Name of Person Filing
		Bihua Chen
	(b)	Address of Principal Business Office or, if none, Residence
		200 Clarendon Street, 52nd Floor Boston, MA 02116
	(c)	Citizenship
		United States
	(d)	Title of Class of Securities
		Class A Ordinary Shares
	(e)	CUSIP Number
		61559X104

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

	(a)	[ ]	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
	(b)	[ ]	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
	(c)	[ ]	Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
	(d)	[ ]	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
	(e)	[ ]	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
	(f)	[ ]	An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
	(g)	[X]	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
	(h)	[ ]	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
	(i)	[ ]	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
	(j)	[ ]	A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
	(k)	[ ]	Group, in accordance with §240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership***

(a)

Amount Beneficially Owned*** The information set forth in Row 9 on the cover page for the Reporting Person is hereby incorporated by reference into this Item 4(a).

(b)

Percent of Class*** The information set forth in Row 11 on the cover page for the Reporting Person is hereby incorporated by reference into this Item 4(b).

(c)

Number of shares as to which such person has: ***

(i)

sole power to vote or to direct the vote

(ii)

shared power to vote or to direct the vote

(iii)

sole power to dispose or to direct the disposition of

(iv)

shared power to dispose or to direct the disposition of

Item 5.

Ownership of Five Percent or Less of a Class

Item 6.

Ownership of More than Five Percent on Behalf of Another Person Each of Cormorant Asset Management, LP, on behalf of the investment funds for which it serves as investment manager, and Helix Holdings LLC has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of the Class A Ordinary Shares.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable.

Item 8.

Identification and Classification of Members of the Group Not applicable.

Item 9.

Notice of Dissolution of Group Not applicable.

Item 10.

Certification

Exhibits

Exhibit